BioCorRx Inc (BICX)
0.73
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
BioCorRx Enterprise Value: 8.888M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 8.888M |
| May 30, 2024 | 8.888M |
| May 29, 2024 | 8.888M |
| May 28, 2024 | 8.888M |
| May 24, 2024 | 9.368M |
| May 23, 2024 | 9.656M |
| May 22, 2024 | 9.560M |
| May 21, 2024 | 9.560M |
| May 20, 2024 | 9.560M |
| May 17, 2024 | 9.656M |
| May 16, 2024 | 10.52M |
| May 15, 2024 | 9.656M |
| May 14, 2024 | 9.368M |
| May 13, 2024 | 8.81M |
| May 10, 2024 | 8.81M |
| May 09, 2024 | 8.81M |
| May 08, 2024 | 8.81M |
| May 07, 2024 | 8.81M |
| May 06, 2024 | 8.81M |
| May 03, 2024 | 8.543M |
| May 02, 2024 | 8.543M |
| May 01, 2024 | 8.543M |
| April 30, 2024 | 8.543M |
| April 29, 2024 | 8.543M |
| April 26, 2024 | 8.543M |
| Date | Value |
|---|---|
| April 25, 2024 | 9.166M |
| April 24, 2024 | 9.166M |
| April 23, 2024 | 8.543M |
| April 22, 2024 | 8.543M |
| April 19, 2024 | 14.95M |
| April 18, 2024 | 14.95M |
| April 17, 2024 | 14.95M |
| April 16, 2024 | 14.95M |
| April 15, 2024 | 15.22M |
| April 12, 2024 | 15.22M |
| April 11, 2024 | 11.92M |
| April 10, 2024 | 15.22M |
| April 09, 2024 | 15.22M |
| April 08, 2024 | 12.55M |
| April 05, 2024 | 11.92M |
| April 04, 2024 | 11.92M |
| April 03, 2024 | 12.10M |
| April 02, 2024 | 10.14M |
| April 01, 2024 | 9.833M |
| March 31, 2024 | 9.833M |
| March 28, 2024 | 9.396M |
| March 27, 2024 | 9.440M |
| March 26, 2024 | 9.440M |
| March 25, 2024 | 9.352M |
| March 22, 2024 | 9.312M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.317M
Minimum
Jan 05 2021
38.07M
Maximum
May 13 2021
15.63M
Average
14.56M
Median
Oct 28 2022
Enterprise Value Benchmarks
| Encompass Health Corp | 11.93B |
| Pediatrix Medical Group Inc | 1.209B |
| US Physical Therapy Inc | 1.751B |
| The Oncology Institute Inc | 59.34M |
| American Oncology Network Inc | 234.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.237M |
| Revenue (Quarterly) | 0.0036M |
| Total Expenses (Quarterly) | 0.8593M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 53.95% |
| Profit Margin (Quarterly) | -34.17K% |
| Earnings Yield | -63.01% |
| Normalized Earnings Yield | -62.46 |